
    
      This study is the prospective randomized controlled clinical trial.

        1. Patient Recruitment: Patients who meets the diagnostic criteria of intra-spinal canal
           tumor and has surgical indications from May 2016 to June 2018 in the department of
           neurosurgery of our hospital could be recruited.

        2. Screening: Demographic characteristics, such as gender, age, history of diseases
           (including but not limited in diabetes, heart disease, smoking history, and operation
           history, etc.), related laboratory tests (blood routing test, liver and kidney
           functions, electrolytes, blood coagulation function, and ECG, etc.) before entering
           either group.

        3. Grouping: Patients who meets the diagnostic criteria and does not meet the exclusion
           criteria would be assigned into the experimental group and control group randomly. The
           informed consent forms should be signed before grouping.

        4. Surgery: Patients in the experimental group will receive operation using microsurgical
           techniques through trans-Quadrant channel pathway. Patients in the control group will
           receive conventional open surgery.

        5. Post-operative Observation and Follow-up: Clinical data will be collected after surgery
           and during follow-up. The time points include the 1st day, 7th day, 30th day, 90th day,
           and 180th day after surgery.

        6. Statistical Analysis: Statisticians are blinded to the clinical data and grouping. The
           software SPSS (V. 16.0) will be used in statistics.
    
  